Pre-treatment with somatostatin in the anaesthetic management of a patient with carcinoid syndrome

33Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Carcinoid syndrome produces flushing, bronchoconstriction and gastrointestinal hypermotility secondary to serotonin, histamine, bradykinin and prostaglandin release. A variety of drugs, foods and anaesthetic agents may provoke this syndrome. Under anaesthesia, the flushing produced may be associated with acute hypotension and cardiovascular collapse; this phenomenon is called a carcinoid crisis. Recently, somatostatin analogue has been used successfully to treat intraoperative carcinoid crisis. In this report, we present a 66-year-old lady with carcinoid syndrome who was pre-treated with 50 μg somatostatin analogue IV and IM prior to surgical manipulation. The anaesthetic course was relatively uneventful and the patient did well postoperatively. © 1988 Canadian Anesthesiologists.

Cite

CITATION STYLE

APA

Parris, W. C. V., Oates, J. A., Kambam, J., Shmerling, R., & Sawyers, J. F. (1988). Pre-treatment with somatostatin in the anaesthetic management of a patient with carcinoid syndrome. Canadian Journal of Anaesthesia, 35(4), 413–416. https://doi.org/10.1007/BF03010865

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free